Timeline Staleness Signal

XNW27011

XNW27011 is flagged as timeline staleness signal because public records show timeline staleness, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Program overview

Context

Indication: Pancreatic Adenocarcinoma Metastatic

Mechanism: Unknown

Modality: Unknown

Sponsor: Evopoint Biosciences .

Scores

Risk-signal summary

Registry: 1/5

Timeline: 4/5

Recruitment burden: 3/5

Results availability: 0/5

Program risk: 4/5

Evidence

Public links

https://clinicaltrials.gov/study/NCT06792435

Linked trials

Trial-level signal details

TrialStatusTimelineResultsBurden
NCT06792435Low Signal (RECRUITING)stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal | long_recruitment_duration_signalLow Signallarge_enrollment_target_signal | few_sites_large_trial_signal | strict_eligibility_signal